Bundick Jason J

Bundick Jason J, EVP, General Counsel, and Corporate Secretary, has demonstrated a balanced but narrowly focused trading pattern centered exclusively on Healthcare Services Group (HCSG), according to SEC Form 4 filings. Over 35 reported transactions, his total buy and sell activity has been nearly even, with $546,385 in purchases and $543,261 in sales. The most notable transactions include a $399,764 disposition on October 27, 2025, and a $263,694 acquisition on January 3, 2025, suggesting periodic rebalancing rather than a sustained directional bias. Smaller transactions, such as a $30,645 sale and an $87,547 sale on February 24, 2026, appear to be part of routine equity management, with several filings reflecting minimal or zero-dollar value adjustments likely tied to awards or plan transactions. Recent activity shows no buys or sells in the latest reporting period, though earlier filings indicate Bundick has engaged in both accumulation and divestment. The absence of trades across multiple companies points to a concentrated position in HCSG, with transactions often clustered around year-end and early-year dates, possibly aligning with compensation-related events. While the dollar values of individual trades vary significantly—from minor $5,400 acquisitions to six-figure dispositions—the overall pattern reflects a measured approach to equity management rather than aggressive buying or selling. The data does not suggest a clear directional trend in Bundick’s recent activity, with his last substantive trade occurring in early 2026.